To be fair, the RSV program subsequently had a setback and Vapendavir hit a wall.
Completely removed any blue sky exuberance for our first year on the NASDAQ.
There is absolutely zero reason to rush into buying BOTA, in other words.
- Forums
- ASX - By Stock
- BTA
- potential breaches of fiduciary duties
potential breaches of fiduciary duties, page-12
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin